OCUGEN, INC.

Profile

Company Names

OCUGEN, INC.

Addresses

5 GREAT VALLEY PARKWAY, SUITE 160, MALVERN, PA 19355

5 GREAT VALLEY PARKWAY, SUITE #160, MALVERN, PA 19355

ONE GREAT VALLEY PARKWAY, SUITE 8, MALVERN, PA 19355

Phone Numbers

(484) 328-4753
484-328-4701
610-590-2140

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$19,050,400.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2018-11-05 
$350,400.00 
$4,000,000.00 
$3,649,600.00 
Equity, Debt 
4
2018-02-01 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity, Debt 
3
2017-05-23 
$7,500,000.00 
$7,500,000.00 
$0.00 
Equity 
2
2016-11-17 
$6,000,000.00 
$6,000,000.00 
$0.00 
Equity, Debt 
1
2016-06-30 
$200,000.00 
$200,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RAVI 
 
ACHAR 
DIRECTOR
OCUGEN, INC.
MARTIN 
 
COYNE 
DIRECTOR
EYENUK, INC.   |  OCUGEN, INC.
SUSAN 
 
DREXLER 
EXECUTIVE OFFICER
OCUGEN, INC.
DANIEL 
 
JORGENSEN 
EXECUTIVE OFFICER
OCUGEN, INC.   |  OCUGEN, INC.
CHARLES 
 
KANG 
EXECUTIVE OFFICER, DIRECTOR
OCUGEN, INC.   |  RESFRAC CORP
UDAY 
 
KOMPELLA 
DIRECTOR, PROMOTER, EXECUTIVE OFFICER
OCUGEN, INC.
HOLDINGS 
 
KVM 
PROMOTER
OCUGEN, INC.
KVM 
 
KVM HOLDINGS, LLC 
PROMOTER
OCUGEN, INC.
FRANK 
 
LEO 
DIRECTOR
IOGENETICS LLC   |  OCUGEN, INC.   |  CUTISPHARMA HOLDINGS, INC.
SHANKAR 
 
MUSUNURI 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
NURON BIOTECH, INC.   |  IOGENETICS LLC   |  OCUGEN, INC.   |  OCUGEN, INC.
MANISH 
 
POTTI 
DIRECTOR
EYENUK, INC.   |  OCUGEN, INC.   |  SOLARIS PHARMA CORP   |  OCUGEN, INC.
MANNISH 
 
POTTI 
DIRECTOR
OCUGEN, INC.
HALIT 
SUHA 
TASPOLATOGLU 
DIRECTOR
OCUGEN, INC.
JOHN 
 
ZHANG 
DIRECTOR
DARWIN LIFE, INC.   |  OCUGEN, INC.
JUNGE 
 
ZHANG 
DIRECTOR
OCUGEN, INC.   |  OCUGEN, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-11-19
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2018-11-05 
2018-02-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2018-02-01 
2017-06-13
D
Link
PHARMACEUTICALS 
 
NOT APPLICABLE 
Equity 
2017-05-23 
2017-02-07
D
Link
BIOTECHNOLOGY 
 
NOT APPLICABLE 
Debt 
2016-06-30 
2017-02-02
D
Link
BIOTECHNOLOGY 
 
NOT APPLICABLE 
Equity, Debt 
2016-11-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#